Showing posts with label Cancer genomics and metabolomics Conferences. Show all posts
Showing posts with label Cancer genomics and metabolomics Conferences. Show all posts

Monday, March 25, 2019

World Hematology 2019: Do you know?

Researchers found that tea drinkers who liked their beverage to be warmer than 60 degrees Celsius (140 degrees Fahrenheit) and consumed more than 700 ml of tea per day (about two large cups) had a 90% higher risk of esophageal cancer, when compared to those who drank less tea and at cooler temperatures.
Esophageal Cancer facts:
  • Esophageal cancer is the eighth most common cancer in the world and is often fatal, killing approximately 400,000 people every year.
  • The American Cancer Society estimates that 13,750 new cases of esophageal cancer will be diagnosed in men and 3,900 new cases in women in the United States in 2019.
To know more about hematology/ Oncology, PS: http://medicines.doctor/haematology5World hematalogy 2019

Friday, March 22, 2019

World Hematology 2019: Do you know?

Today we’ll get to know the answer for the most common severe inherited bleeding disorder in humans. So, let’s go…
What is a bleeding disorder?
Bleeding disorders are a set of conditions that occur when blood can not clot properly. The reason behind the improper blood clotting is because of the proteins which are missing out. Deficiencies of other clotting factors and platelet abnormalities can also cause bleeding disorders. The most common reason to get affected with these kinds of disorders be genetics (inherited from family).
So, here we have the answer for the question. Let’s get to know the answer now, here we go….
The most well-known severe inherited bleeding disorder is Hemophilia but it is relatively rare. The most common inherited bleeding disorder is von Willebrand disease (VWD) in America (almost, all over the world), but, it is less severe when compared to hemophilia and other bleeding disorders. Research shows that as many as 9 out of 10 people with VWD have not been diagnosed.
Hemophilia:
Hemophilia is classified into 2 types based on the type of clotting factor which is lacking and they are:
  • Type A: The person with this type of disorder lacks clotting factor VIII and this is the most common type of hemophilia caused.
  • Type B: The person with this type of disorder lacks clotting factor IX and it is usually less common.
VWD:
There are 3 main types of VWD and they are:
  • Type I: This is the most common form and people with this type of disorder have low von Willebrand factor (VWF) and it is usually mild.
  • Type II: This is caused because of the defect in the VWF structure and there are different Type II defects. It is usually moderate.
  • Type III: This is caused when the people have very little to now VWF. This is the most severe form.
To get to know more about hematology/ oncology, join us on July 24-25, 2019 at Rome, Italy. To know more, PS: http://medicines.doctor/haematology5 

Thursday, March 21, 2019

World Hematology 2019: Do you know?

Do you know the most common severe inherited bleeding disorder in humans?
Got the answer? Please leave your answers in the comment box
To know more about hem/ onc, Join us at Rome, Italy on July 24- 25, 2019
Got to know more? PS: World Hematology 2019….

Monday, March 18, 2019

Track 17: Cancer Pharma Industry

Cancer is one of the most daunting health challenges and a leading cause of death in every corner of the world. The NCI states that the medical costs of cancer care are $125 billion with the rise of 39 percent to $173 billion by the upcoming year. The most common moto of the cancer industry is that it employs too many people and produces too much income to allow for a cure to be found.
Today your business developments are crucial. Join us as a Sponsor/ Exhibitor today. For more info, PS: https://hematology.cmesociety.com/sponsorship | https://hematology.cmesociety.com/exhibition

Thursday, March 14, 2019

World Hematology 2019

Join us at World Hematology 2019 to meet the experts in the field of #Hematology/ #Oncology on July 24- 25, 2019 at Rome, Italy
#Hematology #Conferences #Oncology #Cancer #Hematology_Conferences #Cancer_Conferences #Italy_Conferences #Rome_Conferences #2019_Conferences #Top_Conferences

Tuesday, March 12, 2019

Track 16: Hematology & Oncology Nursing

Hematology nurses are specially trained people who provide care for patients suffering from blood diseases or disorders. They take atmost care in carrying out blood transfusions, blood tests, research and chemotherapy.
Hematology nurses create the plan of care to manage symptoms that result from blood problems. Hematology nursing is most commonly similar to oncology nursing where they help patients manage their pain if their cancer is particularly aggressive or out of reach. Hematology nurses work with adults only in specialized working areas. The responsibilities of these nurses include taking medical histories and performing examinations or blood analysis, administring IVs and working with physicians to diagnose various blood diseases and disorders. Hematology nurses are the back bone for their patients and their families as they teach them how to fight with the diseases and help them manage their blood disease. Advanced practice hematology nurses have some prescriptive authority. Advanced nursing practice in oncology leads to mastery of the nursing process which provides the ability to guide and evaluate nursing practice delivered to individuals diagnosed with cancer. The oncology nurse works with expertise in the multidisciplinary oncology team to achieve realistic healthcare goals for an individual or for an entire community.
Do submit your abstracts in this track and grab your speaker slots now, PS: https://hematology.cmesociety.com/abstract-submission

Saturday, March 9, 2019

World Hematology 2019

World Hematology 2019 takes immense pleasure to share Media Partners.
Hematology is a branch of biology that includes various research areas such as pathology, internal medicine, clinical laboratory, physiology, immunology and pediatrics. This conference will witness a collection of various arenas in Hematology as it involves a vast range of medical streams within it. This conference will be an excellent platform for interdisciplinary interactions to exchange and share knowledge under a single roof.
Join us as Speaker, Delegate, Sponsor or Exhibitor. Save the dates and Grab the Opportunity!!! Register soon!!

Thursday, March 7, 2019

Track 15 : Cancer Drugs and Vaccines

The main purpose of the drug is not to treat cancer but also to relieve the symptoms of cancer. Vaccines have been developed which prevent the infection that occurs due to some carcinogenic viruses. Most of the anti-cancer drugs act by inhibiting DNA synthesis in the cell growth cycle, because anti-cancer drugs generally affect rapidly dividing cells and non-cancerous cells. The site of the cells which is affected determines the side-effects of individual drugs.
Submit your abstracts now and book your slots, PS: https://hematology.cmesociety.com/abstract-submission